Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in RNXT — RenovoRx, Inc.

CIK 1214717 BOSTON, MA
Back to RNXT Full portfolio

Position in RNXT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$415,664
+$30,125 QoQ
Shares Held
424,148
+11.1% QoQ
Ownership
0.940%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 28 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNXT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. RNXT ranks #368 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in RNXT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $415,664 424,148
2026-03-31 $385,539 381,723
2025-12-31 $311,969 371,393
2025-09-30 $471,784 371,484
2025-06-30 $464,987 353,603
2025-03-31 $318,654 321,873
2024-12-31 $304,114 235,748
2024-09-30 $246,912 232,937
2024-06-30 $162,627 143,919
2024-03-31 $89,897 67,088
2023-12-31 $127,688 55,759
2023-09-30 $74,159 55,759
2023-06-30 $95,146 42,100
2023-03-31 $146,718 42,100
2022-12-31 $84,851 36,107
2022-09-30 $69,290 34,302